Emily K Bergsland (Emily Bergsland)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Replacement Therapy

Ejection Fraction

Neuroendocrine Tumors

Top Venues

Cancer research communications

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Erica S Tsang, Mallika S Dhawan, Romain Pacaud, Scott Thomas, Jennifer Grabowsky, Lauren Wilch, Silpa Karipineni, Robin Kate Kelley, Andrew H Ko, Eric Collisson, Jocelyn S Chapman, Stefanie Ueda, Emily K Bergsland, Pamela Munster
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2. JCO precision oncology 8 (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications 4 (7) (2024)
Erica S Tsang, Mallika S Dhawan, Romain Pacaud, Scott Thomas, Jennifer Grabowsky, Lauren Wilch, Silpa Karipineni, Robin Kate Kelley, Andrew H Ko, Eric Collisson, Jocelyn S Chapman, Stefanie Ueda, Emily K Bergsland, Pamela Munster
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2. JCO precision oncology 8 (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications 4 (7) (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications 4 (7) (2024)
Edward B Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, Naoko Takebe, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A Trikalinos, Arash Rezazadeh Kalebasty, Mamta Parikh, Scott A Boerner, Celene Balido, Gregor Krings, Timothy F Burns, Emily K Bergsland, Pamela N Munster, Alan Ashworth, Patricia M LoRusso, Rahul R Aggarwal
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer research communications (2024)
Shivani Majmudar, Stephanie L Graff, Marah N Kays, Beatriz X Braz, Laurie Matt-Amaral, Merry-Jennifer Markham, Ishwaria M Subbiah, Emily K Bergsland, Shikha Jain
The Careers and Professional Well-Being of Women Oncologists During the COVID-19 Pandemic: Responding for Tomorrow. Journal of medical Internet research 25 (2023)
Nitya Raj, Jennifer A Chan, Stephanie J Wang, Rahul R Aggarwal, Susan Calabrese, April DeMore, Lawrence Fong, Jennifer Grabowsky, Thomas A Hope, Kanti Pallav Kolli, Claire K Mulvey, Pamela N Munster, Kimberly Perez, Sippy Punn, Diane Reidy-Lagunes, Sofia Von Fedak, Li Zhang, Emily K Bergsland
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas. British journal of cancer (2023)
Jaydira Del Rivero, Kimberley J Perez, Erin B Kennedy, Erik S Mittra, Namrata Vijayvergia, Junaid Arshad, Sandip Basu, Aman Chauhan, Arvind N Dasari, Andrew M Bellizzi, Alexandra Gangi, Erin Grady, James R Howe, Jana Ivanidze, Mark Lewis, Josh Mailman, Nitya Raj, Heloisa P Soares, Michael C Soulen, Sarah B White, Jennifer A Chan, Pamela L Kunz, Simron Singh, Thorvardur R Halfdanarson, Jonathan R Strosberg, Emily K Bergsland
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Diana Grace Varghese, Jaydira Del Rivero, Emily K Bergsland
Grade Progression and Intrapatient Tumor Heterogeneity as Potential Contributors to Resistance in Gastroenteropancreatic Neuroendocrine Tumors. Cancers 15 (14) (2023)
Stephanie J Wang, Julia Whitman, Alan Paciorek, Bryan Khuong Le, Eric K Nakakura, Spencer C Behr, Nancy Joseph, Li Zhang, Thomas A Hope, Emily K Bergsland
Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time. Journal of neuroendocrinology (2023)
Fangdi Sun, James P Grenert, Lisa Tan, Jessica Van Ziffle, Nancy M Joseph, Claire K Mulvey, Emily K Bergsland
Checkpoint Inhibitor Immunotherapy to Treat Temozolomide-Associated Hypermutation in Advanced Atypical Carcinoid Tumor of the Lung. JCO precision oncology 6 (2022)
Thomas A Hope, Marianne Pavel, Emily K Bergsland
Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (24) (2022)
Nancy N Baxter, Erin B Kennedy, Emily K Bergsland, Jordan D Berlin, Thomas J George, Sharlene Gill, Philip J Gold, Alex Hantel, Lee Jones, Christopher Lieu, Najjia Mahmoud, Arden M Morris, Erika Ruiz-Garcia, Y Nancy You, Jeffrey A Meyerhardt
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (8) (2021)
Matthew H Kulke, Al Bowen Benson, Arvind N Dasari, Lynn Huynh, Beilei Cai, Todor I Totev, Nina Roesner, Mei Sheng Duh, Maureen P Neary, Victoria E Maurer, Brandon E Shih, Cecile G Dagohoy, Jennifer Chan, Emily K Bergsland
Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study. The oncologist 24 (8) (2019)
Arvind N Dasari, Emily K Bergsland, Al Bowen Benson, Beilei Cai, Lynn Huynh, Todor I Totev, Jerome Shea, Mei Sheng Duh, Maureen P Neary, Cecile G Dagohoy, Brandon E Shih, Victoria E Maurer, Jennifer Chan, Matthew H Kulke
Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study. The oncologist 24 (8) (2019)
Maurice Herring, Lynn Huynh, Mei Sheng Duh, Francis Vekeman, Audrey Tiew, Maureen Neary, Emily K Bergsland
Real-world treatment patterns in advanced pancreatic neuroendocrine tumors in the era of targeted therapy: perspectives from an academic tertiary center and community oncology practices. Medical oncology (Northwood, London, England) 34 (5) (2017)